ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

ENVB Enveric Biosciences Inc

0.46
-0.011 (-2.34%)
27 7월(7) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Enveric Biosciences Inc ENVB 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.011 -2.34% 0.46 08:54:35
개장가 저가 고가 종가 전일 종가
0.485 0.453 0.4899 0.4703 0.471
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/07/202421:00BWEnveric Biosciences Announces Preclinical Results Confirming..
15/07/202422:02BWAries Science & Technology and Enveric Biosciences Announce..
15/07/202421:00EDGAR2Form 8-K - Current report
10/07/202421:00BWEnveric Biosciences Announces Patent Granted for Drug..
09/07/202406:10EDGAR2Form S-3 - Registration statement under Securities Act of..
25/06/202421:00BWEnveric Biosciences Provides Strategic Outlook and Pipeline..
04/06/202407:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/05/202421:00BWEnveric Biosciences to Participate in BIO International..
30/05/202405:15EDGAR2Form 8-K - Current report
23/05/202421:00EDGAR2Form 8-K - Current report
18/05/202406:25EDGAR2Form 8-K - Current report
15/05/202419:00BWEnveric Biosciences Reports First Quarter 2024 Financial and..
14/05/202421:00BWEnveric Biosciences Signs $66.5 Million Non-Binding Term..
08/05/202420:00BWEnveric Biosciences Announces Signing of Non-Binding Term..
26/03/202420:00BWEnveric Biosciences Reports Financial Results and Provides..
19/03/202420:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
12/03/202420:00BWEnveric Biosciences Announces New Patent Issuances..
12/03/202401:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/03/202421:00EDGAR2Form 8-K - Current report
29/02/202421:00EDGAR2Form 8-K - Current report
29/02/202421:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
27/02/202406:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202406:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202422:00BWEnveric Biosciences Agrees to Sell Cancer-Targeting..
21/02/202422:05EDGAR2Form 8-K - Current report
21/02/202422:00BWEnveric Biosciences Unveils Library of Preclinical Compounds..
15/02/202405:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/02/202422:05EDGAR2Form 8-K - Current report
07/02/202400:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202407:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/01/202422:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/01/202406:43EDGAR2Form S-3 - Registration statement under Securities Act of..
09/01/202406:42EDGAR2Form 8-K - Current report
03/01/202422:05EDGAR2Form 8-K - Current report
30/12/202306:43EDGAR2Form 8-K - Current report
29/12/202322:52BWEnveric Biosciences Announces Exercise of Warrants and..
28/12/202322:05EDGAR2Form 8-K - Current report
28/12/202322:00BWEnveric Biosciences Selects EB-003 as Lead Drug Candidate..
27/12/202322:05EDGAR2Form 8-K - Current report
27/12/202322:00BWEnveric Biosciences Reports Year End Progress for..
20/12/202322:00BWEnveric Biosciences to Participate in Biotech Showcase 2024..
07/12/202306:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/12/202322:05EDGAR2Form 8-K - Current report
05/12/202322:00BWEnveric Biosciences Selects Development Candidates from..
02/12/202306:31EDGAR2Form S-1/A - General form for registration of securities..
29/11/202322:18EDGAR2Form 8-K - Current report
29/11/202322:00BWEnveric Biosciences Receives Notice of Allowance from USPTO..
27/11/202322:00BWEnveric Biosciences Announces Manuscript Describing the..
24/11/202322:00BWEnveric Biosciences Announces Presentation of Two Posters at..